NovoNutrients bags $18m in Series A to transform CO₂ into nutritional proteins
NovoNutrients, a biotech innovator specializing in converting CO₂ emissions into high-quality protein, announced a successful first closing of its Series A financing. The funding round ... Read More
Seaport Therapeutics rakes in $100m for neuropsychiatric medicine advancement
Seaport Therapeutics, a pioneering clinical-stage biopharmaceutical company, has successfully closed an oversubscribed Series A financing round, securing $100 million. This significant milestone was led by ... Read More